[{"from": "human", "value": "What can you tell me about this molecule? [C][C@@H1][C@H1][Branch2][O][Ring1][C@H1][Branch2][#Branch1][N][O][C@@H1][Branch2][#Branch1][Branch1][C@H1][Ring1][=Branch1][O][C@@H1][C][C][Branch2][=Branch1][=Branch1][C@H1][Branch1][=Branch2][C@@H1][Branch1][Branch1][C@H1][Ring1][=Branch1][O][O][O][C@@H1][C@@H1][Branch2][Ring2][#C][C@H1][Branch2][Ring2][#Branch2][C@@H1][Branch1][P][C@H1][Branch1][Ring2][O][Ring1][=Branch1][C][O][S][=Branch1][C][=O][=Branch1][C][=O][O][O][C@H1][C@@H1][Branch1][P][C@H1][Branch1][=N][C][=C][Branch1][Ring2][O][Ring1][=Branch1][C][=Branch1][C][=O][O-1][O][O][O][N][C][=Branch1][C][=O][C][C][=Branch1][C][=O][O-1][C][O][O][C][C@@H1][Branch2][Ring2][=N][C@H1][Branch2][Ring2][Branch2][C@@H1][Branch1][#Branch2][O][C][Ring1][=Branch1][C][=Branch1][C][=O][O-1][O][C][C@H1][C][O][C@H1][Branch1][Ring2][O][Ring1][Branch1][C@@H1][Branch1][Branch1][C@H1][Ring1][Branch2][O][N][S][=Branch1][C][=O][=Branch1][C][=O][O-1][O][O][N][C][=Branch1][C][=O][C].[Na+1].[Na+1].[Na+1].[Na+1]"}, {"from": "gpt", "value": "The molecule is the sodium salt of enoxaparin, a low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, enoxaprin's mechanism of action is similar to that of heparin, although it exhibits a higher ratio of anti-Factor Xa to anti-Factor IIa activity. This agent also has anti-inflammatory properties, inhibiting monocyte adhesion to tumor necrosis factor alpha- or lipopolysaccharide-activated endothelial cells.  Compared to unfractionated heparins, the use of enoxaparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia."}]